DSpace at RU >

Browsing by Author Kavanaugh, A.

Full Text	Issue Date	Title	Author(s)
	2011	Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010	Furst, D.E.; Keystone, E.C.; Braun, J.; Breedveld, F.C.; Burmester, G.R., et al
	2010	Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009.	Furst, D.E.; Keystone, E.C.; Fleischmann, R.; Mease, P.; Breedveld, F.C., et al
	2009	Adalimumab and methotrextrate combination therapy in patients with early RA sustains clinical remission and response through 5 years of adalimumab treatment.	Pangan, A.; Breedveld, F.C.; Kavanaugh, A.; Riel, P.L.C.M. van; Patra, K., et al
	2009	Desirability Scores for Assessing Multiple Outcomes in Systemic Rheumatic Diseases.	Fransen, J.; Kavanaugh, A.; Borm, G.F.
	2009	Sustained clinical remission and response for early RA patients with adalimumab and methotrexate initial combination therapy: 5-year results of the PREMIER trial.	Keystone, E.C.; Breedveld, F.C.; Kavanaugh, A.; Riel, P.L.C.M. van; Patra, K., et al
	2008	Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008	Furst, D.E.; Keystone, E.C.; Kirkham, B.; Kavanaugh, A.; Fleischmann, R., et al
	2006	Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors.	Fransen, J.; Antoni, C.; Mease, P.J.; Uter, W.; Kavanaugh, A., et al
	2004	Cutting edge diagnostics in rheumatology : The role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology	Wiik, A.S.; Gordon, T.P.; Kavanaugh, A.; Lahita, R.G.; Reeves, W., et al